Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02124902
1:11:cancer,15:50:cancer,99:130:cancer
basal cell or squamous cell carcinoma of the skin which were treated with local resection only or carcinoma in situ of the cervix
3
[ "basal", "cell", "or", "squamous", "cell", "carcinoma", "of", "the", "skin", "which", "were", "treated", "with", "local", "resection", "only", "or", "carcinoma", "in", "situ", "of", "the", "cervix" ]
[ 3, 3, 0, 3, 3, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02340156
9:29:chronic_disease
Serious nonmalignant disease
3
[ "Serious", "nonmalignant", "disease" ]
[ 0, 2, 2 ]
NCT01777035
8:29:chronic_disease
Severe chronic pain syndrome on admission
3
[ "Severe", "chronic", "pain", "syndrome", "on", "admission" ]
[ 0, 2, 2, 2, 0, 0 ]
NCT02660528
20:39:chronic_disease,46:60:chronic_disease,62:75:chronic_disease,77:92:chronic_disease
Recent exposure to uncommon infections (e.g. histoplasmosis, blastomycosis, coccidiomycosis) through recent travel to the Ohio and Mississippi River Valleys and the Southwest
3
[ "Recent", "exposure", "to", "uncommon", "infections", "(", "e.g", ".", "histoplasmosis", ",", "blastomycosis", ",", "coccidiomycosis", ")", "through", "recent", "travel", "to", "the", "Ohio", "and", "Mississippi", "River", "Valleys", "and", "the", "Southwest" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 2, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02441101
35:56:treatment
Left ventricular assist device or heart transplantation
3
[ "Left", "ventricular", "assist", "device", "or", "heart", "transplantation" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT00719888
,,122:153:treatment
Diffusion capacity for carbon monoxide corrected (DLCOcorr) > 50% normal or a pediatric patient who is unable to perform pulmonary function tests (PFTs) but has adequate pulmonary function
3
[ "Diffusion", "capacity", "for", "carbon", "monoxide", "corrected", "(", "DLCOcorr", ")", ">", "50", "%", "normal", "or", "a", "pediatric", "patient", "who", "is", "unable", "to", "perform", "pulmonary", "function", "tests", "(", "PFTs", ")", "but", "has", "adequate", "pulmonary", "function" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02872857
15:32:chronic_disease
Presence of a cerebral aneurysm on computed tomographic angiography (CTA) or Angiogram for which clipping or coiling is possible
3
[ "Presence", "of", "a", "cerebral", "aneurysm", "on", "computed", "tomographic", "angiography", "(", "CTA", ")", "or", "Angiogram", "for", "which", "clipping", "or", "coiling", "is", "possible" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02233868
1:17:treatment
anticholinergics
3
[ "anticholinergics" ]
[ 1 ]
NCT02270450
1:18:chronic_disease
Bowel obstruction below (distal to) ligament of Treitz
3
[ "Bowel", "obstruction", "below", "(", "distal", "to", ")", "ligament", "of", "Treitz" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02317991
1:12:treatment
open biopsy
3
[ "open", "biopsy" ]
[ 1, 1 ]
NCT01880567
17:20:cancer
Newly Diagnosed MCL: Any serious medical condition that places the patient at unacceptable risk and/or would prevent the subject from signing the informed consent form
3
[ "Newly", "Diagnosed", "MCL", ":", "Any", "serious", "medical", "condition", "that", "places", "the", "patient", "at", "unacceptable", "risk", "and/or", "would", "prevent", "the", "subject", "from", "signing", "the", "informed", "consent", "form" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02266329
19:42:chronic_disease,50:65:chronic_disease,67:88:chronic_disease,,106:130:chronic_disease,132:177:chronic_disease,179:203:chronic_disease,,,225:248:chronic_disease,,,
Acute or unstable chronic medical illness (e.g., unstable angina, myocardial infarction within 6 months, congestive heart failure, symptomatic or concerning cardiac arrhythmias; pre-existing hypotension (systolic BP<110) or orthostatic hypotension (systolic drop >20 mm mercury (Hg) after 2 min standing accompanied by lightheadedness)
3
[ "Acute", "or", "unstable", "chronic", "medical", "illness", "(", "e.g.", ",", "unstable", "angina", ",", "myocardial", "infarction", "within", "6", "months", ",", "congestive", "heart", "failure", ",", "symptomatic", "or", "concerning", "cardiac", "arrhythmias", ";", "pre-existing", "hypotension", "(", "systolic", "BP", "<", "110", ")", "or", "orthostatic", "hypotension", "(", "systolic", "drop", ">", "20", "mm", "mercury", "(", "Hg", ")", "after", "2", "min", "standing", "accompanied", "by", "lightheadedness", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 2, 0, 2, 2, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00539162
1:7:cancer,39:51:treatment,55:72:treatment,
Cancer-free and have not received any chemotherapy or radiation therapy for >/=12 months prior to enrolling on this study
3
[ "Cancer-free", "and", "have", "not", "received", "any", "chemotherapy", "or", "radiation", "therapy", "for", ">", "/=12", "months", "prior", "to", "enrolling", "on", "this", "study" ]
[ 3, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02134392
12:38:chronic_disease
History of inflammatory bowel disease
3
[ "History", "of", "inflammatory", "bowel", "disease" ]
[ 0, 0, 2, 2, 2 ]
NCT02402088
1:6:chronic_disease,,,
Obese BMI group: BMI 30-35 as calculated based on height and weight
3
[ "Obese", "BMI", "group", ":", "BMI", "30-35", "as", "calculated", "based", "on", "height", "and", "weight" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02912572
20:60:treatment,52:60:treatment,131:151:treatment,,193:203:treatment
Subjects requiring hormone replacement with corticosteroids are eligible if the steroids are administered only for the purpose of hormonal replacement and at doses ≤ 10 mg or 10 mg equivalent prednisone per day
3
[ "Subjects", "requiring", "hormone", "replacement", "with", "corticosteroids", "are", "eligible", "if", "the", "steroids", "are", "administered", "only", "for", "the", "purpose", "of", "hormonal", "replacement", "and", "at", "doses", "≤", "10", "mg", "or", "10", "mg", "equivalent", "prednisone", "per", "day" ]
[ 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT00967577
78:90:cancer,99:114:cancer,159:175:treatment,192:217:treatment
Histologically, or cytologically documented, advanced stage, malignant adult solid tumors (except prostate cancer) that are refractory to, or recurrent from, standard therapy or for which no curative standard therapy exists
3
[ "Histologically", ",", "or", "cytologically", "documented", ",", "advanced", "stage", ",", "malignant", "adult", "solid", "tumors", "(", "except", "prostate", "cancer", ")", "that", "are", "refractory", "to", ",", "or", "recurrent", "from", ",", "standard", "therapy", "or", "for", "which", "no", "curative", "standard", "therapy", "exists" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 1, 0 ]
NCT01675154
1:37:treatment,9:16:treatment,22:37:treatment,39:46:treatment
Current therapy with anti-coagulants, digoxin and anti-arrhythmics
3
[ "Current", "therapy", "with", "anti-coagulants", ",", "digoxin", "and", "anti-arrhythmics" ]
[ 1, 1, 1, 1, 0, 1, 0, 0 ]
NCT02744352
1:23:chronic_disease
Chronic pain syndromes
3
[ "Chronic", "pain", "syndromes" ]
[ 2, 2, 2 ]
NCT00358657
1:15:chronic_disease
Fanconi anemia
3
[ "Fanconi", "anemia" ]
[ 2, 2 ]
NCT02213497
,,,103:122:treatment,163:165:treatment,169:189:treatment
Patients with primary tumors exceeding 8 cm in length or 5 cm in width ( length should be measured by endoscopic findings, width should be measured by diagnostic CT or CT portion of PET/CT)
3
[ "Patients", "with", "primary", "tumors", "exceeding", "8", "cm", "in", "length", "or", "5", "cm", "in", "width", "(", "length", "should", "be", "measured", "by", "endoscopic", "findings", ",", "width", "should", "be", "measured", "by", "diagnostic", "CT", "or", "CT", "portion", "of", "PET/CT", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT02759211
33:35:chronic_disease
Confirmed clinical diagnosis of MS
3
[ "Confirmed", "clinical", "diagnosis", "of", "MS" ]
[ 0, 0, 0, 0, 2 ]
NCT02050347
13:22:chronic_disease
Mixed donor chimerism (any level)
3
[ "Mixed", "donor", "chimerism", "(", "any", "level", ")" ]
[ 0, 0, 2, 0, 0, 0, 0 ]
NCT02762266
15:28:chronic_disease,
Patients with liver disease classified as Child Pugh class A or B
3
[ "Patients", "with", "liver", "disease", "classified", "as", "Child", "Pugh", "class", "A", "or", "B" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02127398
1:17:chronic_disease,44:65:chronic_disease,85:106:treatment,108:139:treatment
Active infection at other sites (excluding Clostridium difficile) requiring ongoing antibacterial therapy (antiviral or antifungal therapy is acceptable)
3
[ "Active", "infection", "at", "other", "sites", "(", "excluding", "Clostridium", "difficile", ")", "requiring", "ongoing", "antibacterial", "therapy", "(", "antiviral", "or", "antifungal", "therapy", "is", "acceptable", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 1, 1, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT02849639
25:36:allergy_name,67:77:allergy_name,81:100:allergy_name,,196:202:treatment
No contraindications to Aβ-PET scan including hypersensitivity to PET ligand or radiation exposures in the past year that would exceed the acceptable safe annual exposure in combination with the Aβ PET
3
[ "No", "contraindications", "to", "Aβ-PET", "scan", "including", "hypersensitivity", "to", "PET", "ligand", "or", "radiation", "exposures", "in", "the", "past", "year", "that", "would", "exceed", "the", "acceptable", "safe", "annual", "exposure", "in", "combination", "with", "the", "Aβ", "PET" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02520427
,,127:137:treatment
Women who are lactating/breastfeeding or who plan to breastfeed while on sudy through 1 week after receiving the last dose of study drug
3
[ "Women", "who", "are", "lactating/breastfeeding", "or", "who", "plan", "to", "breastfeed", "while", "on", "sudy", "through", "1", "week", "after", "receiving", "the", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02653287
110:113:chronic_disease
include meeting at least 4 of 11 American College of Rheumatology (ACR) classification criteria for definite SLE, or 3 out of 11 ACR classification criteria with also meeting at least one SLICC criteria
3
[ "include", "meeting", "at", "least", "4", "of", "11", "American", "College", "of", "Rheumatology", "(", "ACR", ")", "classification", "criteria", "for", "definite", "SLE", ",", "or", "3", "out", "of", "11", "ACR", "classification", "criteria", "with", "also", "meeting", "at", "least", "one", "SLICC", "criteria" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01905046
23:44:treatment,
Administration of any investigational agent =< 30 days prior to pre-registration
3
[ "Administration", "of", "any", "investigational", "agent", "=", "<", "30", "days", "prior", "to", "pre-registration" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02390752
18:58:cancer
Individuals with malignant peripheral nerve sheath tumors will not be eligible to participate in the phase II portion of the trial
3
[ "Individuals", "with", "malignant", "peripheral", "nerve", "sheath", "tumors", "will", "not", "be", "eligible", "to", "participate", "in", "the", "phase", "II", "portion", "of", "the", "trial" ]
[ 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02169089
84:100:treatment,102:115:chronic_disease,117:133:treatment
Any surgical or medical condition which might alter pharmacokinetics of drug (e.g. renal transplant, liver failure, liver transplant)
3
[ "Any", "surgical", "or", "medical", "condition", "which", "might", "alter", "pharmacokinetics", "of", "drug", "(", "e.g", ".", "renal", "transplant", ",", "liver", "failure", ",", "liver", "transplant", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0 ]
NCT02167958
1:30:cancer,34:53:cancer,,99:108:treatment,120:140:treatment,168:189:treatment,219:250:treatment
Marginal zone B-cell lymphoma or follicular lymphoma that has progressed after at least two prior therapies (excluding single agent Rituxan) and are ineligible for an autologous transplant or relapsed/progressed after autologous stem cell transplant
3
[ "Marginal", "zone", "B-cell", "lymphoma", "or", "follicular", "lymphoma", "that", "has", "progressed", "after", "at", "least", "two", "prior", "therapies", "(", "excluding", "single", "agent", "Rituxan", ")", "and", "are", "ineligible", "for", "an", "autologous", "transplant", "or", "relapsed/progressed", "after", "autologous", "stem", "cell", "transplant" ]
[ 3, 3, 3, 3, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02589600
,20:34:treatment,36:45:treatment,50:70:treatment,,,168:183:treatment
Women currently on bisphosphonate, denosumab, or teriparatide therapy or who have been on a bisphosphonate for greater than 1 year during the previous 2 years because bisphosphonates are long acting
3
[ "Women", "currently", "on", "bisphosphonate", ",", "denosumab", ",", "or", "teriparatide", "therapy", "or", "who", "have", "been", "on", "a", "bisphosphonate", "for", "greater", "than", "1", "year", "during", "the", "previous", "2", "years", "because", "bisphosphonates", "are", "long", "acting" ]
[ 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02177695
1:26:cancer,28:47:cancer,53:81:cancer
pure small cell carcinoma, pure adenocarcinoma, and pure squamous cell carcinoma histologies
3
[ "pure", "small", "cell", "carcinoma", ",", "pure", "adenocarcinoma", ",", "and", "pure", "squamous", "cell", "carcinoma", "histologies" ]
[ 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02822378
12:27:chronic_disease
history of spinal stenosis
3
[ "history", "of", "spinal", "stenosis" ]
[ 0, 0, 2, 2 ]
NCT02192398
13:21:treatment,,,
On a stable morphine equivalent dose of at least 60mg/day and ≤ 240mg/day for at least 3 months
3
[ "On", "a", "stable", "morphine", "equivalent", "dose", "of", "at", "least", "60mg/day", "and", "≤", "240mg/day", "for", "at", "least", "3", "months" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02548351
26:35:chronic_disease
Histological presence of cirrhosis
3
[ "Histological", "presence", "of", "cirrhosis" ]
[ 0, 0, 0, 2 ]
NCT02414139
1:26:treatment
Strong inducers of CYP3A4
3
[ "Strong", "inducers", "of", "CYP3A4" ]
[ 1, 1, 1, 1 ]
NCT02574650
,,37:52:treatment,
Any PCI within 30 days prior to the index procedure or planned 3 months post the index procedure
3
[ "Any", "PCI", "within", "30", "days", "prior", "to", "the", "index", "procedure", "or", "planned", "3", "months", "post", "the", "index", "procedure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01787487
15:27:cancer,59:74:cancer,88:97:treatment
patients with malignancies with indolent behavior such as prostate cancer treated with radiation
3
[ "patients", "with", "malignancies", "with", "indolent", "behavior", "such", "as", "prostate", "cancer", "treated", "with", "radiation" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 3, 3, 0, 0, 1 ]
NCT02204098
58:66:treatment,75:86:allergy_name,88:93:allergy_name,98:120:allergy_name
Known allergy, or history of serious adverse reaction to vaccines such as anaphylaxis, hives, or respiratory difficulty
3
[ "Known", "allergy", ",", "or", "history", "of", "serious", "adverse", "reaction", "to", "vaccines", "such", "as", "anaphylaxis", ",", "hives", ",", "or", "respiratory", "difficulty" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 4, 0, 4, 0, 0, 4, 4 ]
NCT01883076
,70:92:treatment
Child not completing all pre-procedure work-up within 10 days of the Stage II Glenn surgery as listed in section 6 of this protocol AND lack of pre-procedure work-up documented as a safety concern by a site investigator
3
[ "Child", "not", "completing", "all", "pre-procedure", "work-up", "within", "10", "days", "of", "the", "Stage", "II", "Glenn", "surgery", "as", "listed", "in", "section", "6", "of", "this", "protocol", "AND", "lack", "of", "pre-procedure", "work-up", "documented", "as", "a", "safety", "concern", "by", "a", "site", "investigator" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02594111
1:10:treatment
verapamil
3
[ "verapamil" ]
[ 1 ]
NCT01553071
19:36:chronic_disease,,,,
Poorly-controlled diabetes mellitus, as defined as fasting serum glucose concentration over 200 mg/dl or a hemoglobin A1C over 7.5%
3
[ "Poorly-controlled", "diabetes", "mellitus", ",", "as", "defined", "as", "fasting", "serum", "glucose", "concentration", "over", "200", "mg/dl", "or", "a", "hemoglobin", "A1C", "over", "7.5", "%" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02016781
1:32:cancer,36:51:cancer,52:79:cancer,94:97:cancer
Chronic myelomonocytic leukemia or myelodysplastic/myeloproliferative neoplasm (unacceptable MDS subtypes)
3
[ "Chronic", "myelomonocytic", "leukemia", "or", "myelodysplastic/myeloproliferative", "neoplasm", "(", "unacceptable", "MDS", "subtypes", ")" ]
[ 3, 3, 3, 0, 3, 3, 0, 0, 3, 0, 0 ]
NCT02808442
1:30:cancer
CD19-negative B-cell leukemia
3
[ "CD19-negative", "B-cell", "leukemia" ]
[ 3, 3, 3 ]
NCT03029442
1:40:chronic_disease
Acute fracture or extensive bone trauma
3
[ "Acute", "fracture", "or", "extensive", "bone", "trauma" ]
[ 2, 2, 2, 2, 2, 2 ]
NCT02939755
16:32:chronic_disease,34:43:chronic_disease,55:72:chronic_disease
no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported
3
[ "no", "evidence", "of", "thought", "disorder", ",", "delusions", ",", "or", "active", "suicidal", "ideation", "is", "observed", "or", "reported" ]
[ 0, 0, 0, 2, 2, 0, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT03078504
12:28:treatment
listed for organ transplant
3
[ "listed", "for", "organ", "transplant" ]
[ 0, 0, 1, 1 ]
NCT02635360
11:26:cancer
Confirmed cervical cancer
3
[ "Confirmed", "cervical", "cancer" ]
[ 0, 3, 3 ]
NCT03071328
39:69:cancer
Histologically confirmed diagnosis of adenocarcinoma of the prostate
3
[ "Histologically", "confirmed", "diagnosis", "of", "adenocarcinoma", "of", "the", "prostate" ]
[ 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT01389024
1:37:chronic_disease,46:58:chronic_disease,60:80:chronic_disease,82:103:chronic_disease,136:155:chronic_disease,
Upper or lower respiratory infection, active bronchospasm, acute chest syndrome, splenic sequestration or other acute complications of sickle cell disease other than pain in the last 4 weeks (from resolution of symptoms)
3
[ "Upper", "or", "lower", "respiratory", "infection", ",", "active", "bronchospasm", ",", "acute", "chest", "syndrome", ",", "splenic", "sequestration", "or", "other", "acute", "complications", "of", "sickle", "cell", "disease", "other", "than", "pain", "in", "the", "last", "4", "weeks", "(", "from", "resolution", "of", "symptoms", ")" ]
[ 2, 2, 2, 2, 2, 0, 0, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02016924
8:41:chronic_disease
Active hepatitis C virus (HCV) infection
3
[ "Active", "hepatitis", "C", "virus", "(", "HCV", ")", "infection" ]
[ 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02978638
1:17:chronic_disease
Immunosuppressed subjects
3
[ "Immunosuppressed", "subjects" ]
[ 2, 0 ]
NCT01430390
48:60:cancer,,109:132:treatment,134:143:treatment,145:157:treatment,165:179:treatment
Relapse on this protocol is detection of CD19+ malignancies in bone marrow ≥ 5% or extramedullary lesion by morphology cytogenetics, molecular, radiographic and/or flow cytometry
3
[ "Relapse", "on", "this", "protocol", "is", "detection", "of", "CD19+", "malignancies", "in", "bone", "marrow", "≥", "5", "%", "or", "extramedullary", "lesion", "by", "morphology", "cytogenetics", ",", "molecular", ",", "radiographic", "and/or", "flow", "cytometry" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 0, 1, 1 ]
NCT02565498
1:19:treatment
Prior radiotherapy to the target site
3
[ "Prior", "radiotherapy", "to", "the", "target", "site" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT02250664
1:16:chronic_disease,
Suicide attempt in the past 6 months
3
[ "Suicide", "attempt", "in", "the", "past", "6", "months" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02106598
1:20:chronic_disease,32:59:chronic_disease,64:102:chronic_disease
cardiac arrhythmias other than chronic atrial fibrillation and chronic active or persistent hepatitis
3
[ "cardiac", "arrhythmias", "other", "than", "chronic", "atrial", "fibrillation", "and", "chronic", "active", "or", "persistent", "hepatitis" ]
[ 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT01802346
1:39:treatment
Prior therapy with inhibitors of IGF-1
3
[ "Prior", "therapy", "with", "inhibitors", "of", "IGF-1" ]
[ 1, 1, 1, 1, 1, 1 ]
NCT02232516
1:47:cancer
Subcutaneous panniculitis-like T-cell lymphoma
3
[ "Subcutaneous", "panniculitis-like", "T-cell", "lymphoma" ]
[ 3, 3, 3, 3 ]
NCT02632721
46:56:treatment
Patients must be eligible for treatment with decitabine
3
[ "Patients", "must", "be", "eligible", "for", "treatment", "with", "decitabine" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02579096
7:17:treatment
Prior febuxostat use
3
[ "Prior", "febuxostat", "use" ]
[ 0, 1, 0 ]
NCT03048448
1:28:chronic_disease,,,
Moderate hepatic impairment (Group 1): Child-Pugh Class B (7-9 points)
3
[ "Moderate", "hepatic", "impairment", "(", "Group", "1", ")", ":", "Child-Pugh", "Class", "B", "(", "7-9", "points", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02057133
13:22:treatment,,25:36:treatment,84:104:treatment,109:127:cancer,157:181:treatment
For Part F (LY2835219 + trastuzumab):The participant must have received at least 1 chemotherapy regimen for metastatic disease and may be receiving ongoing therapy with trastuzumab
3
[ "For", "Part", "F", "(", "LY2835219", "+", "trastuzumab", ")", ":", "The", "participant", "must", "have", "received", "at", "least", "1", "chemotherapy", "regimen", "for", "metastatic", "disease", "and", "may", "be", "receiving", "ongoing", "therapy", "with", "trastuzumab" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 3, 3, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02234193
23:35:treatment
Subjects taking daily oral aspirin
3
[ "Subjects", "taking", "daily", "oral", "aspirin" ]
[ 0, 0, 0, 1, 1 ]
NCT02801539
4:30:treatment,
On enzyme replacement therapy for ≥ 26 weeks at pretest
3
[ "On", "enzyme", "replacement", "therapy", "for", "≥", "26", "weeks", "at", "pretest" ]
[ 0, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02128802
7:26:treatment
Prior anti-reflux surgery
3
[ "Prior", "anti-reflux", "surgery" ]
[ 0, 1, 1 ]
NCT02145351
1:28:chronic_disease
Hypertrophic cardiomyopathy
3
[ "Hypertrophic", "cardiomyopathy" ]
[ 2, 2 ]
NCT02573493
45:119:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to any of the agents used in this study
3
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "any", "of", "the", "agents", "used", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 0, 0, 0, 0 ]
NCT02349867
50:67:treatment,94:117:chronic_disease,119:154:chronic_disease,156:181:chronic_disease,183:218:chronic_disease,220:239:chronic_disease,268:286:chronic_disease,298:314:chronic_disease
Experienced any of the following toxicities with prior gemcitabine adminstration (if given): capillary leak syndrome, posterior reversible encephalopathy, hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, unexplained dyspnea or other evidence of severe pulmonary toxicity, or severe hepatic toxicity
3
[ "Experienced", "any", "of", "the", "following", "toxicities", "with", "prior", "gemcitabine", "adminstration", "(", "if", "given", ")", ":", "capillary", "leak", "syndrome", ",", "posterior", "reversible", "encephalopathy", ",", "hemolytic", "uremic", "syndrome", ",", "thrombotic", "thrombocytopenic", "purpura", ",", "unexplained", "dyspnea", "or", "other", "evidence", "of", "severe", "pulmonary", "toxicity", ",", "or", "severe", "hepatic", "toxicity" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2 ]
NCT02458014
15:28:cancer,120:123:cancer,149:161:treatment,,294:311:treatment,313:358:chronic_disease,
Patients with B-lineage ALL in hematologic complete remission (CR) with molecular failure (i.e., had never achieved an MRD-negativity status before blinatumomab) or had a molecular relapse (i.e., became MRD positive after having been MRD negative) starting at any time point after 3 months of frontline therapy; molecular disease or minimal residual disease is defined by a value of at least of 1 x 10-4 (0.01%) by multicolor flow cytometry and/or by next generation sequencing (NGS)
3
[ "Patients", "with", "B-lineage", "ALL", "in", "hematologic", "complete", "remission", "(", "CR", ")", "with", "molecular", "failure", "(", "i.e.", ",", "had", "never", "achieved", "an", "MRD-negativity", "status", "before", "blinatumomab", ")", "or", "had", "a", "molecular", "relapse", "(", "i.e.", ",", "became", "MRD", "positive", "after", "having", "been", "MRD", "negative", ")", "starting", "at", "any", "time", "point", "after", "3", "months", "of", "frontline", "therapy", ";", "molecular", "disease", "or", "minimal", "residual", "disease", "is", "defined", "by", "a", "value", "of", "at", "least", "of", "1", "x", "10-4", "(", "0.01", "%", ")", "by", "multicolor", "flow", "cytometry", "and/or", "by", "next", "generation", "sequencing", "(", "NGS", ")" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 3, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02281409
13:24:treatment,29:35:chronic_disease,55:65:treatment,
Subjects on prophylaxis for herpes who started taking medication at least 30 days prior to study entry, should continue to take the prescribed medication for the duration of the study
3
[ "Subjects", "on", "prophylaxis", "for", "herpes", "who", "started", "taking", "medication", "at", "least", "30", "days", "prior", "to", "study", "entry", ",", "should", "continue", "to", "take", "the", "prescribed", "medication", "for", "the", "duration", "of", "the", "study" ]
[ 0, 0, 1, 0, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00788164
1:14:chronic_disease
Lichen planus
3
[ "Lichen", "planus" ]
[ 2, 2 ]
NCT02573493
66:69:chronic_disease,128:135:chronic_disease,139:142:treatment
Arm 3: Presence of disease at the oropharynx sub-sites, which is HPV-related as verified by p16, a surrogate marker of HPV, or HPV ISH or PCR
3
[ "Arm", "3", ":", "Presence", "of", "disease", "at", "the", "oropharynx", "sub-sites", ",", "which", "is", "HPV-related", "as", "verified", "by", "p16", ",", "a", "surrogate", "marker", "of", "HPV", ",", "or", "HPV", "ISH", "or", "PCR" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02657993
113:123:treatment
Experiencing ongoing pain and/or stiffness in one or more joints, which started or worsened after initiation of AI therapy
3
[ "Experiencing", "ongoing", "pain", "and/or", "stiffness", "in", "one", "or", "more", "joints", ",", "which", "started", "or", "worsened", "after", "initiation", "of", "AI", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03040778
15:41:chronic_disease
Patients with serious cardiac arrhythmia
3
[ "Patients", "with", "serious", "cardiac", "arrhythmia" ]
[ 0, 0, 2, 2, 2 ]
NCT02995733
7:11:chronic_disease,48:60:chronic_disease,127:142:chronic_disease,144:169:chronic_disease,188:209:treatment,211:225:chronic_disease,227:234:chronic_disease,240:266:chronic_disease
Dx of COPD in a never smoker without any other lung disease or any other disease that might cause airway obstruction such as: Cystic Fibrosis, Connective Tissue Disease, premature birth, organ transplantation, bronchiectasis, sarcoid, and obliterative bronchiolitis
3
[ "Dx", "of", "COPD", "in", "a", "never", "smoker", "without", "any", "other", "lung", "disease", "or", "any", "other", "disease", "that", "might", "cause", "airway", "obstruction", "such", "as", ":", "Cystic", "Fibrosis", ",", "Connective", "Tissue", "Disease", ",", "premature", "birth", ",", "organ", "transplantation", ",", "bronchiectasis", ",", "sarcoid", ",", "and", "obliterative", "bronchiolitis" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 1, 1, 0, 2, 0, 2, 0, 0, 2, 2 ]
NCT02496208
1:36:cancer,38:45:cancer,47:53:cancer,55:67:cancer
Urothelial carcinoma of the bladder, urethra, ureter, renal pelvis
3
[ "Urothelial", "carcinoma", "of", "the", "bladder", ",", "urethra", ",", "ureter", ",", "renal", "pelvis" ]
[ 3, 3, 3, 3, 3, 0, 3, 0, 3, 0, 3, 3 ]
NCT02451423
1:21:treatment,31:42:treatment,46:60:treatment
Inactivated vaccines (such as hepatitis A or polio vaccines) are permitted during the study
3
[ "Inactivated", "vaccines", "(", "such", "as", "hepatitis", "A", "or", "polio", "vaccines", ")", "are", "permitted", "during", "the", "study" ]
[ 1, 1, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02474199
27:30:chronic_disease,34:37:chronic_disease,51:64:treatment
No detectible circulating EBV or CMV DNA prior to Treg infusion, assessed at the time of PBMC collection for manufacture
3
[ "No", "detectible", "circulating", "EBV", "or", "CMV", "DNA", "prior", "to", "Treg", "infusion", ",", "assessed", "at", "the", "time", "of", "PBMC", "collection", "for", "manufacture" ]
[ 0, 0, 0, 2, 0, 2, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03143985
,,109:118:treatment,209:212:treatment,216:224:treatment
Men must agree to use a latex or synthetic condom during sexual contact with a FCBP even if they have had a vasectomy from the time of signing the informed consent form through 60 days after the last dose of POM or TEW-7197
3
[ "Men", "must", "agree", "to", "use", "a", "latex", "or", "synthetic", "condom", "during", "sexual", "contact", "with", "a", "FCBP", "even", "if", "they", "have", "had", "a", "vasectomy", "from", "the", "time", "of", "signing", "the", "informed", "consent", "form", "through", "60", "days", "after", "the", "last", "dose", "of", "POM", "or", "TEW-7197" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT02287558
1:20:chronic_disease,,
Renal insufficiency, serum creatinine > 2.0 mg/dl
3
[ "Renal", "insufficiency", ",", "serum", "creatinine", ">", "2.0", "mg/dl" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02177292
1:22:treatment,
Prostate tumor biopsy grading by Gleason score classification is mandatory prior to registration (Appendix V)
3
[ "Prostate", "tumor", "biopsy", "grading", "by", "Gleason", "score", "classification", "is", "mandatory", "prior", "to", "registration", "(", "Appendix", "V", ")" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02498951
11:23:treatment,,,
high-dose methotrexate is defined as >= 3 grams/m^2; methotrexate dose reduction for creatinine clearance < 100 ml/min is permitted
3
[ "high-dose", "methotrexate", "is", "defined", "as", ">", "=", "3", "grams/m^2", ";", "methotrexate", "dose", "reduction", "for", "creatinine", "clearance", "<", "100", "ml/min", "is", "permitted" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02133196
12:54:allergy_name
History of severe immediate hypersensitivity reaction to any of the agents used in this study
3
[ "History", "of", "severe", "immediate", "hypersensitivity", "reaction", "to", "any", "of", "the", "agents", "used", "in", "this", "study" ]
[ 0, 0, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02540616
5:25:chronic_disease
Any active skin disorder that affects skin integrity of the scalp
3
[ "Any", "active", "skin", "disorder", "that", "affects", "skin", "integrity", "of", "the", "scalp" ]
[ 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02188745
5:35:treatment,
Any investigational cancer therapy in the last 28 days
3
[ "Any", "investigational", "cancer", "therapy", "in", "the", "last", "28", "days" ]
[ 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02915744
14:32:treatment,
Last dose of anticancer therapy must have been administered within 6 months of the date of randomization into this study
3
[ "Last", "dose", "of", "anticancer", "therapy", "must", "have", "been", "administered", "within", "6", "months", "of", "the", "date", "of", "randomization", "into", "this", "study" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00716066
1:35:chronic_disease
Autoimmune cerebellar degeneration
3
[ "Autoimmune", "cerebellar", "degeneration" ]
[ 2, 2, 2 ]
NCT02233322
18:27:treatment,33:42:treatment,47:57:treatment,149:173:chronic_disease
May be receiving treatment with phosphate and calcitriol, but must be willing to undergo dose adjustments by the investigators if iron resolves the phosphate wasting defect
3
[ "May", "be", "receiving", "treatment", "with", "phosphate", "and", "calcitriol", ",", "but", "must", "be", "willing", "to", "undergo", "dose", "adjustments", "by", "the", "investigators", "if", "iron", "resolves", "the", "phosphate", "wasting", "defect" ]
[ 0, 0, 0, 1, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02385110
42:58:chronic_disease,71:81:cancer,100:120:chronic_disease
Any serious/and or unstable pre-existing medical disorder (aside from malignancy exception above), psychiatric disorder, or other conditions that could interfere with subject's safety, obtaining informed consent or compliance to the study procedures
3
[ "Any", "serious/and", "or", "unstable", "pre-existing", "medical", "disorder", "(", "aside", "from", "malignancy", "exception", "above", ")", ",", "psychiatric", "disorder", ",", "or", "other", "conditions", "that", "could", "interfere", "with", "subject", "'s", "safety", ",", "obtaining", "informed", "consent", "or", "compliance", "to", "the", "study", "procedures" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 3, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01953263
44:66:chronic_disease,70:90:chronic_disease,102:138:treatment
Patients with evidence or diagnosis of any primary muscle disease or coagulation disorder (including concomitant anti-coagulation therapy)
3
[ "Patients", "with", "evidence", "or", "diagnosis", "of", "any", "primary", "muscle", "disease", "or", "coagulation", "disorder", "(", "including", "concomitant", "anti-coagulation", "therapy", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 2, 0, 0, 1, 1, 1, 0 ]
NCT01937949
1:11:chronic_disease,13:23:chronic_disease,27:67:chronic_disease,
Juxtarenal, suprarenal or type IV thoracoabdominal aortic aneurysm with a diameter ≥ 5.0 cm or 2 times the normal aortic diameter
3
[ "Juxtarenal", ",", "suprarenal", "or", "type", "IV", "thoracoabdominal", "aortic", "aneurysm", "with", "a", "diameter", "≥", "5.0", "cm", "or", "2", "times", "the", "normal", "aortic", "diameter" ]
[ 2, 0, 2, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00875342
8:17:treatment
Use of pacemaker
3
[ "Use", "of", "pacemaker" ]
[ 0, 0, 1 ]
NCT01554371
,,,152:168:treatment,
Female patient of childbearing potential must have a negative serum or urine pregnancy test β-hCG within 72 hours prior to receiving the first dose of study medication and agree to the use of effective methods of contraception while on study
3
[ "Female", "patient", "of", "childbearing", "potential", "must", "have", "a", "negative", "serum", "or", "urine", "pregnancy", "test", "β-hCG", "within", "72", "hours", "prior", "to", "receiving", "the", "first", "dose", "of", "study", "medication", "and", "agree", "to", "the", "use", "of", "effective", "methods", "of", "contraception", "while", "on", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02094625
1:10:treatment,
Cisplatin must be delivered over <3 day
3
[ "Cisplatin", "must", "be", "delivered", "over", "<", "3", "day" ]
[ 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02435992
,49:66:chronic_disease,68:83:chronic_disease,88:105:chronic_disease
Current or recent (within 3 months) evidence of fulminant colitis, toxic megacolon, or bowel perforation
3
[ "Current", "or", "recent", "(", "within", "3", "months", ")", "evidence", "of", "fulminant", "colitis", ",", "toxic", "megacolon", ",", "or", "bowel", "perforation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2 ]
NCT01896999
29:59:cancer
other histologies including lymphocyte predominant (LP) HL are not permitted
3
[ "other", "histologies", "including", "lymphocyte", "predominant", "(", "LP", ")", "HL", "are", "not", "permitted" ]
[ 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0 ]
NCT02151175
15:23:chronic_disease,25:33:chronic_disease,38:47:chronic_disease
Subjects with dementia, delirium and psychotic symptoms
3
[ "Subjects", "with", "dementia", ",", "delirium", "and", "psychotic", "symptoms" ]
[ 0, 0, 2, 0, 2, 0, 2, 0 ]
NCT02355535
1:26:treatment,31:49:cancer,98:116:treatment,118:145:treatment,147:159:treatment,161:177:treatment,182:205:treatment
Prior systemic treatments for metastatic disease are permitted but may not be ongoing, including targeted therapies, biologic response modifiers, chemotherapy, hormonal therapy, or investigational therapy
3
[ "Prior", "systemic", "treatments", "for", "metastatic", "disease", "are", "permitted", "but", "may", "not", "be", "ongoing", ",", "including", "targeted", "therapies", ",", "biologic", "response", "modifiers", ",", "chemotherapy", ",", "hormonal", "therapy", ",", "or", "investigational", "therapy" ]
[ 1, 1, 1, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 0, 1, 0, 1, 1, 0, 0, 1, 1 ]